Successful use of tocilizumab in a patient with psoriatic arthritis

Rheumatology (United Kingdom)

Volumn 52, Issue 9, 2013, Pages 1728-1729

  Hughes, Michael ^a   Chinoy, Hector ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; HEMOGLOBIN; INTERLEUKIN 6; METHOTREXATE; RITUXIMAB; TOCILIZUMAB;

ADULT; CASE REPORT; CELL DIFFERENTIATION; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REFRACTORY PERIOD; TREATMENT DURATION; TREATMENT FAILURE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84882992107     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes432     Document Type: Letter

References (5)

1. Atzeni F, Ventura D, Batticciotto A et al. Interleukin 6 blockade: tocilizumab in psoriatic arthritis. J Rheumatol 201289:97-9.
2. Wendling D, Letho-Gyselinck H, Guillot X et al. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis. J Rheumatol 201239:657.
3. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 200654: 2665-73.
4. Kuijk V, Tak PP. Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy. Curr Rheumatol Rep 201113: 353-9.
5. Ogataa A, Umegakib N, Katayamab I et al. Psoriatic arthritis in two patients with an inadequate response to treatment. Joint Bone Spine 201279:85-7.